Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amifostine 375 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Imiglucerase 400 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Raltitrexed 2 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Verteporfin 15 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Glatiramer acetate 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Trastuzumab 150 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Infliximab 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Imiglucerase 200 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metylprednisolon 1 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metylprednisolon 2 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
metylprednisolon 125 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Hydralazine hydrochloride 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metylprednisolon 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
metylprednisolon 40 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Bendamustine hydrochloride 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Romidepsin 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely rilonacept 220 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely enfuvirtide 90 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefotaximnatrium 2 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely streptokinase 750000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Drotrecogin alfa 5 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Warfarin sodium 5 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Bacitracin A 50000 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Mezlocillin (as mezlocillin sodium) 3 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Mezlocillin (as mezlocillin sodium) 4 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely noxytiolin 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|